Literature DB >> 3052771

Cranial dystonia, blepharospasm and hemifacial spasm: clinical features and treatment, including the use of botulinum toxin.

S P Kraft1, A E Lang.   

Abstract

Blepharospasm, the most frequent feature of cranial dystonia, and hemifacial spasm are two involuntary movement disorders that affect facial muscles. The cause of blepharospasm and other forms of cranial dystonia is not known. Hemifacial spasm is usually due to compression of the seventh cranial nerve at its exit from the brain stem. Cranial dystonia may result in severe disability. Hemifacial spasm tends to be much less disabling but may cause considerable distress and embarrassment. Patients affected with these disorders are often mistakenly considered to have psychiatric problems. Although the two disorders are quite distinct pathophysiologically, therapy with botulinum toxin has proven very effective in both. We review the clinical features, proposed pathophysiologic features, differential diagnosis and treatment, including the use of botulinum toxin, of cranial dystonia and hemifacial spasm.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3052771      PMCID: PMC1268337     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  53 in total

1.  Blepharospasm-oromandibular dystonia syndrome (Brueghel's syndrome). A variant of adult-onset torsion dystonia?

Authors:  C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-12       Impact factor: 10.154

2.  Etiology and definitive microsurgical treatment of hemifacial spasm. Operative techniques and results in 47 patients.

Authors:  P J Jannetta; M Abbasy; J C Maroon; F M Ramos; M S Albin
Journal:  J Neurosurg       Date:  1977-09       Impact factor: 5.115

3.  Dystonia and tremor in spasmodic torticollis.

Authors:  J R Couch
Journal:  Adv Neurol       Date:  1976

4.  Meige's syndrome. Dyskinesia of the eyelids and facial muscles.

Authors:  G W Paulson
Journal:  Geriatrics       Date:  1972-08

5.  Hemifacial spasm.

Authors:  P B Eckman; R A Kramer; P H Altrocchi
Journal:  Arch Neurol       Date:  1971-07

6.  Familial reflex blepharospasm.

Authors:  A R Irvine; R B Daroff; M D Sanders; W F Hoyt
Journal:  Am J Ophthalmol       Date:  1968-06       Impact factor: 5.258

7.  Botulinum toxin: mechanism of presynaptic blockade.

Authors:  I Kao; D B Drachman; D L Price
Journal:  Science       Date:  1976-09-24       Impact factor: 47.728

8.  Biofeedback treatment of blepharospasm with spasmodic torticollis.

Authors:  M R Roxanas; M R Thomas; M S Rapp
Journal:  Can Med Assoc J       Date:  1978-07-08       Impact factor: 8.262

9.  Differential section of the facial nerve for blepharospasm.

Authors:  D H Reynolds; J L Smith; T J Walsh
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1967 Jul-Aug

10.  Clinical aspects of spasmodic dysphonia.

Authors:  M J Aminoff; H H Dedo; K Izdebski
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-04       Impact factor: 10.154

View more
  14 in total

Review 1.  The cranial nerve vascular compression syndrome: I. A review of treatment.

Authors:  A R Møller
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

Review 2.  Meige syndrome: what's in a name?

Authors:  Mark S LeDoux
Journal:  Parkinsonism Relat Disord       Date:  2009-05-19       Impact factor: 4.891

Review 3.  Secondary blepharospasm associated with structural lesions of the brain.

Authors:  M A Khooshnoodi; S A Factor; H A Jinnah
Journal:  J Neurol Sci       Date:  2013-06-06       Impact factor: 3.181

4.  Efficacy and Safety of Long-Term Therapy with Type A Botulinum Toxin in Patients with Blepharospasm.

Authors:  Francisco Vivancos-Matellano; Ana Rodríguez-Sanz; Yolanda Herrero-Infante; Javier Mascías-Cadavid
Journal:  Neuroophthalmology       Date:  2018-11-26

5.  Mixed results for GPi-DBS in the treatment of cranio-facial and cranio-cervical dystonia symptoms.

Authors:  Natlada Limotai; Criscely Go; Genko Oyama; Nelson Hwynn; Theresa Zesiewicz; Kelly Foote; Roongroj Bhidayasiri; Irene Malaty; Pam Zeilman; Ramon Rodriguez; Michael S Okun
Journal:  J Neurol       Date:  2011-05-07       Impact factor: 4.849

Review 6.  Efficacy and safety of long-term botulinum toxin treatment in craniocervical dystonia: a systematic review.

Authors:  Carlo Colosimo; Dorina Tiple; Alfredo Berardelli
Journal:  Neurotox Res       Date:  2012-02-23       Impact factor: 3.911

7.  Is increased blinking a form of blepharospasm?

Authors:  Antonella Conte; Giovanni Defazio; Gina Ferrazzano; Mark Hallett; Antonella Macerollo; Giovanni Fabbrini; Alfredo Berardelli
Journal:  Neurology       Date:  2013-06-11       Impact factor: 9.910

8.  Application of electrophysiological methods and magnetic resonance tomographic angiography in the differentiation between hemifacial spasm and Meige syndrome.

Authors:  Chuyi Huang; Suhua Miao; Heling Chu; Aikeremujiang Muheremu; Jinting Wu; Rongsong Zhou; Huancong Zuo; Yu Ma
Journal:  Neurol Sci       Date:  2016-02-02       Impact factor: 3.307

9.  Botulinum toxin paralysis of the orbicularis oculi muscle. Types and time course of alterations in muscle structure, physiology and lid kinematics.

Authors:  A K Horn; J D Porter; C Evinger
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

10.  Hemifacial spasm: 20-year surgical experience, lesson learned.

Authors:  Hector Soriano-Baron; Olivia Vales-Hidalgo; Emiliano Arvizu-Saldana; Sergio Moreno-Jimenez; Rogelio Revuelta-Gutierrez
Journal:  Surg Neurol Int       Date:  2015-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.